Consolidated Statements of Changes in Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Treasury Stock	Accumulated Other Comprehensive Loss	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022		61,279,379
Balance at January 1 at Dec. 31, 2022	$ 382,267	$ 613	$ 1,105,701	$ (468,879)	$ (16,261)	$ (238,907)
Beginning balance (in shares) at Dec. 31, 2022				(26,685,542)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of shares related to stock-based compensation (in shares)		729,549		(58,541)
Issuance of shares related to stock-based compensation	6,319	$ 8	7,465	$ (1,154)
Exercise of stock warrants (in shares)		651,855
Exercise of stock warrants	15,898	$ 6	15,892
Stock-based compensation expense	22,201		22,201
Settlement of indemnification asset (in shares)				(613,954)
Settlement of indemnification asset	(15,760)			$ (15,760)
Foreign currency translation adjustment, net of tax	1,070				1,070
Net (loss) income	(259,295)					(259,295)
Ending balance (in shares) at Dec. 31, 2023		62,660,783
Balance at December 31 at Dec. 31, 2023	152,700	$ 627	1,151,259	$ (485,793)	(15,191)	(498,202)
Ending balance (in shares) at Dec. 31, 2023				(27,358,037)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of shares related to stock-based compensation (in shares)		1,323,707		(138,248)
Issuance of shares related to stock-based compensation	7,165	$ 13	9,763	$ (2,611)
Stock-based compensation expense	24,118		24,118
Common stock offering (in shares)		6,572,250
Common stock offering	$ 87,402	$ 66	87,336
Repurchases of common stock (in shares)	(26,495)			(26,495)
Repurchases of common stock	$ (499)			$ (499)
Foreign currency translation adjustment, net of tax	250				250
Net (loss) income	$ (74,216)					(74,216)
Ending balance (in shares) at Dec. 31, 2024	43,033,960	70,556,740
Balance at December 31 at Dec. 31, 2024	$ 196,920	$ 706	1,272,476	$ (488,903)	(14,941)	(572,418)
Ending balance (in shares) at Dec. 31, 2024	(27,522,780)			(27,522,780)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of shares related to stock-based compensation (in shares)		1,445,389		(286,081)
Issuance of shares related to stock-based compensation	$ 1,231	$ 14	5,418	$ (4,201)
Stock-based compensation expense	$ 25,250		25,250
Repurchases of common stock (in shares)	(378,000)			(378,000)
Repurchases of common stock	$ (4,999)			$ (4,999)
Foreign currency translation adjustment, net of tax	(570)				(570)
Net (loss) income	$ 307					307
Ending balance (in shares) at Dec. 31, 2025	43,815,268	72,002,129
Balance at December 31 at Dec. 31, 2025	$ 218,139	$ 720	$ 1,303,144	$ (498,103)	$ (15,511)	$ (572,111)
Ending balance (in shares) at Dec. 31, 2025	(28,186,861)			(28,186,861)